Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rivera

Showing results (1431-1440 of 1,448) with videos related to

Pageof 145
Sort By:
Journal of Medicinal Chemistry|June 2, 2010
Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase including the T315I gatekeeper mutantWei-Sheng Huang, Chester A Metcalf, Raji Sundaramoorthi, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2022
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancerWei-Sheng Huang, Feng Li, Yongjin Gong, et al.
Blood|June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyVanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
Nature Human Behaviour|July 16, 2025
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
Nature Communications|June 22, 2019
Lessons from the reestablishment of Public Health Laboratory activities in Puerto Rico after Hurricane MariaMargaret C Hardy, Rita C Stinnett, Kristine J Kines, et al.
Multiple Sclerosis and Related Disorders|June 5, 2021
Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAMJuan I Rojas, Edgar Carnero Contentti, Patricio Abad, et al.
Nature Biomedical Engineering|August 26, 2024
Standardizing designed and emergent quantitative features in microphysiological systemsDennis M Nahon, Renée Moerkens, Hande Aydogmus, et al.
Therapeutic Advances in Gastroenterology|June 9, 2021
The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19Isabel Campos-Varela, Ares Villagrasa, Macarena Simon-Talero, et al.
Neurology International|March 24, 2022
Neuromyelitis Optica Spectrum Disorder in Central America and the Caribbean: A Multinational Clinical Characterization StudyFernando Gracia, Deyanira Ramírez, Alexander Parajeles-Vindas, et al.
Pageof 145

Showing results (1431-1440 of 1,448) with videos related to

Sort By:
Pageof 145
Journal of Medicinal Chemistry|June 2, 2010
Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase including the T315I gatekeeper mutantWei-Sheng Huang, Chester A Metcalf, Raji Sundaramoorthi, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2022
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancerWei-Sheng Huang, Feng Li, Yongjin Gong, et al.
Blood|June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyVanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
Nature Human Behaviour|July 16, 2025
The development of aperiodic neural activity in the human brainZachariah R Cross, Samantha M Gray, Adam J O Dede, et al.
Nature Communications|June 22, 2019
Lessons from the reestablishment of Public Health Laboratory activities in Puerto Rico after Hurricane MariaMargaret C Hardy, Rita C Stinnett, Kristine J Kines, et al.
Multiple Sclerosis and Related Disorders|June 5, 2021
Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAMJuan I Rojas, Edgar Carnero Contentti, Patricio Abad, et al.
Nature Biomedical Engineering|August 26, 2024
Standardizing designed and emergent quantitative features in microphysiological systemsDennis M Nahon, Renée Moerkens, Hande Aydogmus, et al.
Therapeutic Advances in Gastroenterology|June 9, 2021
The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19Isabel Campos-Varela, Ares Villagrasa, Macarena Simon-Talero, et al.
Neurology International|March 24, 2022
Neuromyelitis Optica Spectrum Disorder in Central America and the Caribbean: A Multinational Clinical Characterization StudyFernando Gracia, Deyanira Ramírez, Alexander Parajeles-Vindas, et al.
Pageof 145